T-Lymphocyte Activation Is Correlated With the Presence of Anti-EBV in Patients With Laryngeal Squamous Cell Carcinoma
- 29 October 2019
- journal article
- research article
- Published by International Institute of Anticancer Research in In Vivo
- Vol. 33 (6) , 2007-2012
Abstract
Background/Aim: Chronic viral infection is an important risk factor in the development of cancer. Failure of immune response to clear the oncogenic infection can facilitate cancer progression. The aim of the present study was to analyze early and late activation of T-lymphocytes related to Epstein-Barr virus (EBV) infection by the expression of markers of activation (CD69, CD25) on the surface of T-lymphocytes (CD3+, CD4+, CD8+) in patients bearing laryngeal cancer according to absence/presence immunoglobulin G antibodies to EBV nuclear antigen (EBNA1). Materials and Methods: Thirty-three patients with laryngeal squamous cell carcinoma (LC) and 20 volunteers without cancer (control group) were enrolled in the study. Peripheral blood samples were collected from every individual. The markers of activation of T-lymphocytes were determined by flow cytometry, whereas commercial immunoenzymatic assay kits were used for detection of anti-viral capsid antigen (VCA) IgM, anti-VCA IgG, and anti-EBNA1 IgG. Results: Increased early activation of CD8+ and CD4+ T-lymphocytes was found in patients with LC. There was a significantly higher proportion of CD4+ and CD8+T-lymphocytes expressing CD69 antigen in patients with LC compared to the control group. The proportion of CD4+ CD25+ T-lymphocytes in patients with LC positive for anti-EBNA1 IgG and anti-VCA IgM was lower compared to patients without antibodies to VCA IgM. Conclusion: The dysfunction of immune response in larynx cancer patients could be associated with EBV infection.Keywords
This publication has 34 references indexed in Scilit:
- Host–tumor interactions in nasopharyngeal carcinomasSeminars in Cancer Biology, 2012
- Immunotherapy for head and neck cancerAnti-Cancer Drugs, 2011
- Human peripheral blood and bone marrow Epstein–Barr virus‐specific T‐cell repertoire in latent infection reveals distinct memory T‐cell subsetsEuropean Journal of Immunology, 2010
- Immune responses to Epstein–Barr virus: molecular interactions in the virus evasion of CD8+ T cell immunityMicrobes and Infection, 2010
- EBV CHRONIC INFECTIONSMediterranean Journal of Hematology and Infectious Diseases, 2010
- Regulatory T cell activity in primary and persistent Epstein–Barr virus infectionJournal of Medical Virology, 2009
- Prognostic Value of Tumor-Infiltrating CD4+ T-Cell Subpopulations in Head and Neck CancersClinical Cancer Research, 2006
- Presence of activated T lymphocytes in peripheral blood of head and neck squamous cell carcinoma patients predicts impaired prognosisActa Oto-Laryngologica, 2006
- Treatment of nasopharyngeal carcinoma with Epstein-Barr virus–specific T lymphocytesBlood, 2005
- Decreased Absolute Counts of T Lymphocyte Subsets and Their Relation to Disease in Squamous Cell Carcinoma of the Head and NeckClinical Cancer Research, 2004